Drug intelligence / Profile preview

UrgoTul SSD

Development stage
Unknown
Lead developer
URGO
Modality
Small Molecules
Administration
Topical
01

Overview

**UrgoTul SSD** is a topical antibacterial wound-contact-layer medical device developed by Urgo Medical. It consists of a non-adherent polyester mesh incorporating Technology Lipido-Colloid with silver, including carboxymethylcellulose hydrocolloid, petrolatum, and silver sulfadiazine. In contact with wound exudate, the lipido-colloid matrix supports a moist wound environment and atraumatic dressing removal, while silver sulfadiazine provides local broad-spectrum antimicrobial activity. It has been used for second-degree burns and infected or infection-prone acute and chronic wounds, including leg ulcers and diabetic foot ulcers. ([hmpgloballearningnetwork.com](https://www.hmpgloballearningnetwork.com/site/wounds/content/comparison-two-silver-dressings-wound-management-pediatric-burns))

Brand names
UrgoTul SSD
Other names
Urgotul SSD
02

Targets

DNADHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on UrgoTul SSD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UrgoTul SSD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call